Grifols SA GRF-ES:Mercado Continuo

*Data is delayed | Exchange | EUR
Last | 5:35 PM CEST
9.29quote price arrow down-0.23 (-2.46%)
Volume
2,640,079
52 week range
6.36 - 15.92
Loading...
  • Open9.53
  • Day High9.53
  • Day Low9.25
  • Prev Close9.52
  • 52 Week High15.92
  • 52 Week High Date12/29/23
  • 52 Week Low6.36
  • 52 Week Low Date03/06/24

Key Stats

  • Market Cap6,512.55M
  • Shares Out679.09M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-

KEY STATS

  • Open9.53
  • Day High9.53
  • Day Low9.25
  • Prev Close9.52
  • 52 Week High15.92
  • 52 Week High Date12/29/23
  • 52 Week Low6.36
  • 52 Week Low Date03/06/24
  • Market Cap6,512.55M
  • Shares Out679.09M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.09
  • P/E (TTM)103.06
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Grifols SA

 

Profile

MORE
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing...
Thomas Glanzmann
Chairman, Executive Director
Jose Ignacio Abia
Chief Executive Officer, Executive Director
Alfredo Arroyo Guerra
Chief Financial Officer
Miguel Angel Louzan Garcia
Chief Digital Information Officer
Address
C/ Jesus y Maria, 6
Barcelona, BAR
08022
Spain